Viewing Study NCT04391595


Ignite Creation Date: 2025-12-24 @ 1:30 PM
Ignite Modification Date: 2026-01-01 @ 1:55 AM
Study NCT ID: NCT04391595
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-02-28
First Post: 2020-05-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: LY3214996 Plus Abemaciclib in Recurrent Glioblastoma Patients
Sponsor: Nader Sanai
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module